Search

Your search keyword '"Huber, Sylwia"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Huber, Sylwia" Remove constraint Author: "Huber, Sylwia"
43 results on '"Huber, Sylwia"'

Search Results

1. Multi-parameter optimization: Development of a morpholin-3-one derivative with an improved kinetic profile for imaging monoacylglycerol lipase in the brain

3. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson’s disease brain as revealed by multicolor STED microscopy

4. Propensities of Fatty Acid-Modified ASOs: Self-Assembly vs Albumin Binding

6. Additional file 1 of Multi-platform quantitation of alpha-synuclein human brain proteoforms suggests disease-specific biochemical profiles of synucleinopathies

7. Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe

11. Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides

13. Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells

14. Reply to Alarcon and Borroto: Small molecule AX-024 reduces T cell proliferation independently of CD3ε-Nck1 interaction at SH3.1

15. Small molecule AX-024 reduces T cell proliferation independently of CD3ϵ/Nck1 interaction, which is governed by a domain swap in the Nck1-SH3.1 domain

16. Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells

17. Highly Specific, Fluorescent Cannabinoid Type 2 Receptor Probes Enable Applications in Microscopy, Flow Cytometry and FRET-based Binding Assays

18. Drug Derived Fluorescent Probes for the Specific Visualization of Cannabinoid Type 2 Receptor - A Toolbox Approach

19. Detailed structural orchestration of Lewy pathology in Parkinson's disease as revealed by 3D multicolor STED microscopy

21. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome

22. Subcellular orchestration of alpha-synuclein variants in Parkinson’s disease brains revealed by 3D multicolor STED microscopy

23. Synthetic single domain antibodies for the conformational trapping of membrane proteins

24. Synthetic single domain antibodies for the conformational trapping of membrane proteins

25. Synthetic single domain antibodies for the conformational trapping of membrane proteins

26. Author response: Synthetic single domain antibodies for the conformational trapping of membrane proteins

27. Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers

28. Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia

29. HtrA1 activation is driven by an allosteric mechanism of inter-monomer communication

30. SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands

31. Potent and Selective BACE-1 Peptide Inhibitors Lower Brain Aβ Levels Mediated by Brain Shuttle Transport

33. A comparative study of binding properties of gantenerumab and aducanumab analog to aggregated amyloid-beta (P6.087)

34. Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling

35. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.

39. Structure of the Acid-sensing ion channel 1 in complex with the gating modifier Psalmotoxin 1

42. Helicobacter pylori CagL dependent induction of gastrin expression via a novel &agr;v&bgr;5-integrineintegrin linked kinase signalling complex.

43. Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling.

Catalog

Books, media, physical & digital resources